GlassScriptPhysician profile
Paul Fred Ives
NPI 1922090323
$3,687.27
in general payments reported to CMS, 2019-2025
18 companies · $561 in 2025
The $561 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $902 · 2020: $164 · 2021: $305 · 2022: $462 · 2023: $747 · 2024: $547 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,105.49 | 2022-2025 | Infuse, Ultra Multifocal Toric, Infuse Multifocal |
| Allergan, INC. | $472.48 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $326.31 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $313.11 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $200.88 | 2022-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $193.57 | 2025 | Xdemvy |
| New World Medical,INC. | $192.25 | 2025 | Via360, Kahook Dual Blade, Streamline |
| Shire North American Group INC | $157.85 | 2019 | |
| Dompe US, INC. | $124.48 | 2023 | Oxervate |
| Maculogix, INC. | $119.91 | 2019-2021 | |
| Lkc Technologies, INC. | $117.42 | 2023-2025 | |
| Optovue, INC. | $108.99 | 2019 | |
| Spark Therapeutics, INC. | $104.18 | 2019 | |
| Biotissue Holdings INC. | $46.53 | 2019-2024 | |
| Coopervision INC. | $43.67 | 2022-2024 | Myday Contact Lens |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $34.57 | 2024 | Tyrvaya |
| Alcon Vision LLC | $13.36 | 2023 | Total30 |
| Abb Con-Cise Optical Group LLC | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Ives listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.